2025-03-13 04:02:41
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Lasa Supergenerics Ltd reports jump Q4FY22 PAT to Rs. 12.28 crores
Posted On : 2022-04-11 14:01:42( TIMEZONE : IST )
Lasa Supergenerics Limited has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 51.2216 crores during the period ended March 31, 2022 as compared to Rs. 15.7504 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 12.2843 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. -4.7141 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 3.02 for the period ended March 31, 2022 as compared to Rs. -1.16 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 51.2216 crs | ₹15.7504 crs |  225.21% |
| Net Profit | ₹12.2843 crs | ₹-4.7141 crs | 360.59% |
| EPS | ₹3.02 | ₹-1.16 | 360.34% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 51.2216 crores during the period ended March 31, 2022 as compared to Rs.39.1067 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.12.2843 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.3.7980 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.3.02 for the period ended March 31, 2022 as compared to Rs.0.93 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 51.2216 crs | ₹39.1067 crs | 30.98% |
| Net Profit | ₹12.2843 crs | ₹3.7980 crs | 223.44% |
| EPS | ₹3.02 | ₹0.93 | 224.73% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.137.1840 crores during the Financial Year ended March 31, 2022 as compared to Rs.202.4371 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-5.3672 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.22.7777 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.-1.32 for the Financial Year ended March 31, 2022 as compared to Rs.5.60 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹137.1840 crs | ₹202.4371 crs |  -32.23% |
| Net Profit | ₹-5.3672 crs | ₹22.7777 crs | -123.56% |
| EPS | ₹-1.32 | ₹5.60 | -123.57% |
Shares of Lasa Supergenerics Limited was last trading in BSE at Rs. 54.10 as compared to the previous close of Rs. 49.15. The total number of shares traded during the day was 50789 in over 524 trades.
The stock hit an intraday high of Rs. 56.55 and intraday low of 49.15. The net turnover during the day was Rs. 2711790.00.
